Similar articles

Abstract: Objective: The purpose of this meta-analysis was to explore the effect of corticosteroids on atrial fibrillation (AF) following catheter ablation. Methods: We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials for published articles describing the effect of corticosteroids in preventing AF recurrence after catheter ablation. Data on study and patient were extracted. Risk ratios (RRs) and 95% confidence intervals (CIs) were calculated by use of a random-effect model, and P values of <0.05 were considered significant. Results: Two randomized controlled trials (RCTs) and three cohort studies involving 846 patients were included in this meta-analysis. Within one month of catheter ablation, corticosteroid use was associated with a declined risk of recurrence of AF in RCT (RR 0.57, 95% CI 0.39 to 0.85, P=0.005), but without significant effect in cohort studies (RR 1.01, 95% CI 0.79 to 1.30, P=0.94). After three months of catheter ablation, corticosteroids did not have a significant effect in the prevention of late recurrence of AF in either RCT (RR 0.78, 95% CI 0.38 to 1.59, P=0.49) or cohort studies (RR 0.96, 95% CI 0.70 to 1.31, P=0.78). Conclusions: Our meta-analysis suggested that periprocedural administration of corticosteroids of catheter ablation was associated with reduction of early but not late recurrence of AF.

皮质类固醇对导管消融术后心房颤动影响的荟萃分析

[1]Amdur RL, Mukherjee M, Go A, et al., 2016. Interleukin-6 is a risk factor for atrial fibrillation in chronic kidney disease: findings from the CRIC study. PLoS ONE, 11(2):e0148189.

[2]Andrade JG, Khairy P, Nattel S, et al., 2013. Corticosteroid use during pulmonary vein isolation is associated with a higher prevalence of dormant pulmonary vein conduction. Heart Rhythm, 10(10):1569-1575.

[3]Barnes PJ, 2006. How corticosteroids control inflammation: quintiles prize lecture 2005. Br J Pharmacol, 148(3):245-254.

[4]Belvisi MG, 2004. Regulation of inflammatory cell function by corticosteroids. Proc Am Thorac Soc, 1(3):207-214.

[5]Conway DS, Buggins P, Hughes E, et al., 2004. Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. Am J Cardiol, 94(4):508-510.

[6]Coutinho AE, Chapman KE, 2011. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol, 335(1):2-13.

[7]Deftereos S, Giannopoulos G, Kossyvakis C, et al., 2012. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J Am Coll Cardiol, 60(18):1790-1796.

[8]Deftereos S, Giannopoulos G, Efremidis M, et al., 2014. Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life. Heart Rhythm, 11(4):620-628.

[9]Deng H, Xue YM, Zhan XZ, et al., 2011. Role of tumor necrosis factor-alpha in the pathogenesis of atrial fibrillation. Chin Med J (Engl), 124(13):1976-1982.

[10]Dernellis J, Panaretou M, 2004. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J, 25(13):1100-1107.

[11]Ganesan AN, Shipp NJ, Brooks AG, et al., 2013. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc, 2:e004549.

[12]Gurses KM, Kocyigit D, Yalcin MU, et al., 2016. Monocyte toll-like receptor expression in patients with atrial fibrillation. Am J Cardiol, 117(9):1463-1467.

[13]Haïssaguerre M, Jaïs P, Shah DC, et al., 1998. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med, 339(10):659-666.

[14]Harada M, van Wagoner DR, Nattel S, 2015. Role of inflammation in atrial fibrillation pathophysiology and management. Circ J, 79(3):495-502.

[15]Ho KM, Tan JA, 2009. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation, 119(14):1853-1866.

[16]Hu YF, Yeh HI, Tsao HM, et al., 2012. Electrophysiological correlation and prognostic impact of heat shock protein 27 in atrial fibrillation. Circ Arrhythm Electrophysiol, 5(2):334-340.

[17]Kannel WB, Abbott RD, Savage DD, et al., 1982. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med, 306(17):1018-1022.

[18]Kim DR, Won H, Uhm JS, et al., 2015. Comparison of two different doses of single bolus steroid injection to prevent atrial fibrillation recurrence after radiofrequency catheter ablation. Yonsei Med J, 56(2):324-331.

[19]Kim YR, Nam GB, Han S, et al., 2015. Effect of short-term steroid therapy on early recurrence during the blanking period after catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol, 8(6):1366-1372.

[20]Koyama T, Tada H, Sekiguchi Y, et al., 2010. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial. J Am Coll Cardiol, 56(18):1463-1472.

[21]Letsas KP, Weber R, Bürkle G, et al., 2009. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace, 11(2):158-163.

[22]Li T, Sun ZL, Xie QY, 2016. Meta-analysis identifies serum C-reactive protein as an indicator of atrial fibrillation risk after coronary artery bypass graft. Am J Ther, 23(6):e1586-e1596.

[23]Lip GY, Tse HF, Lane DA, 2012. Atrial fibrillation. Lancet, 379(9816):648-661.

[24]Patel D, Shaheen M, Venkatraman P, et al., 2009. Omega-3 polyunsaturated fatty acid supplementation reduced atrial fibrillation recurrence after pulmonary vein antrum isolation. Indian Pacing Electrophysiol J, 9(6):292-298.

[25]Ren Y, Zeng RX, Li JJ, et al., 2015. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction: a systematic review and meta-analysis. Int J Cardiol, 190:268-270.

[26]Richter B, Gwechenberger M, Socas A, et al., 2012. Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol, 101(3):217-225.

[27]Roger VL, Go AS, Lloyd-Jones DM, et al., 2012. Executive summary: heart disease and stroke statistics—2012 update: a report from the American heart association. Circulation, 125(1):188-197.

[28]Scridon A, Dobreanu D, Chevalier P, et al., 2015. Inflammation, a link between obesity and atrial fibrillation. Inflamm Res, 64(6):383-393.

[29]Smit MD, Maass AH, de Jong AM, et al., 2012. Role of inflammation in early atrial fibrillation recurrence. Europace, 14(6):810-817.

[30]van Osch D, Dieleman JM, van Dijk D, et al., 2015. Dexamethasone for the prevention of postoperative atrial fibrillation. Int J Cardiol, 182:431-437.

[31]Won H, Kim JY, Shim J, et al., 2013. Effect of a single bolus injection of low-dose hydrocortisone for prevention of atrial fibrillation recurrence after radiofrequency catheter ablation. Circ J, 77(1):53-59.

[32]Wu ZK, Laurikka J, Vikman S, et al., 2008. High postoperative interleukin-8 levels related to atrial fibrillation in patients undergoing coronary artery bypass surgery. World J Surg, 32(12):2643-2649.

[33]Yang M, Tan H, Cheng L, et al., 2007. Expression of heat shock proteins in myocardium of patients with atrial fibrillation. Cell Stress Chaperones, 12(2):142-150.